Novartis AG
TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY A BETA-BLOCKER
Last updated:
Abstract:
The present invention relates to methods of treating autoimmune diseases with siponimod in patients receiving additionally a beta-blocker.
Status:
Application
Type:
Utility
Filling date:
23 Mar 2021
Issue date:
13 Jan 2022